Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2010-07-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
首次公开发行A股初步询价及推介公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "Initial Public Offering (IPO) A-share Preliminary Inquiry and Promotion Announcement" for 嘉事堂药业股份有限公司. It details the process, dates, and procedures for the IPO, including the initial pricing inquiry, promotion meetings, and subscription arrangements. It references regulatory approvals and specific dates for the offering process. The document is an announcement related to the IPO process and initial pricing inquiry, not a financial report or earnings release. It is not a full report but an announcement of the offering and related promotional activities. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2010-07-27 Chinese
内部控制鉴证报告
Audit Report / Information Classification · 95% confidence The document is an internal control attestation report issued by a certified public accounting firm (BDO China Shu Lun Pan) for Jia Shi Tang Pharmaceutical Co., Ltd. It includes an auditor's opinion on the effectiveness of the company's internal control over financial reporting as of December 31, 2009. The document contains detailed descriptions of the company's internal control environment, control procedures, and management's self-evaluation of internal controls. It is not a full annual report or financial statement but a standalone audit-related report focused on internal control effectiveness. The document is lengthy (over 10,000 characters) and contains substantive content, not merely an announcement or certification letter. Therefore, it fits the definition of an Audit Report / Information (AR) which includes standalone audit reports and internal control attestation reports. FY 2009
2010-07-27 Chinese
首次公开发行股票招股意向书
Capital/Financing Update Classification · 95% confidence The document is titled as a 招股意向书, which translates to a "Prospectus" or "Offering Intention Document" for the company's initial public offering (IPO). It contains detailed information about the stock issuance, shareholder commitments, risk factors, company background, financial data, management, governance, and plans for the use of raised funds. This type of document is typically part of the IPO filing process and is not an annual report, earnings release, or other routine financial report. It is a comprehensive disclosure document related to capital raising and stock issuance. According to the filing definitions, updates on company fundraising or capital structure changes fall under Capital/Financing Update (CAP). Therefore, this IPO prospectus should be classified as a Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the actual filing, not just an announcement or summary.
2010-07-27 Chinese
国务院国有资产监督管理委员会关于公司国有股转持有关问题的批复
Regulatory Filings
2010-07-27 Chinese
北京市中咨律师事务所关于公司首次公开发行股票并上市的法律意见书
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding the initial public offering (IPO) and listing of a company (嘉事堂药业股份有限公司). It references Chinese securities laws, company law, and regulations related to the issuance and listing of shares. The document includes extensive legal verification of the company's qualifications, shareholder structure, capital changes, and compliance with regulatory requirements for a stock issuance and listing. It is not a financial report, earnings release, or management discussion, but a legal opinion specifically related to the IPO process. This type of document is typically classified as a Regulatory Filing (RNS) because it is a legal opinion letter supporting the IPO filing, not the IPO prospectus itself or a financial report. The document is lengthy and substantive but does not contain financial statements or earnings data itself, nor is it a proxy, audit report, or governance report. Therefore, the best fit is Regulatory Filings (RNS).
2010-07-27 Chinese
关于公司首次公开发行A股项目证券发行保荐书
Capital/Financing Update Classification · 95% confidence The document is a detailed '证券发行保荐书' (Securities Issuance Sponsorship Letter) related to 嘉事堂药业股份有限公司's initial public offering (IPO) of A shares. It includes extensive information about the company, the sponsors, legal compliance, internal audit procedures, and regulatory adherence. The document is lengthy (15,000 characters) and contains substantive content about the IPO process, company background, and regulatory compliance, rather than just an announcement or a brief summary. This type of document is a formal sponsorship or underwriting report related to a capital market transaction, specifically an IPO. According to the filing definitions, updates on company fundraising or capital structure changes fall under 'Capital/Financing Update (CAP)'. This document is not an Annual Report, Audit Report, nor a simple announcement. It is a comprehensive report related to the company's capital issuance and listing process. Therefore, the most appropriate classification is 'CAP' (Capital/Financing Update).
2010-07-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.